HARM REDUCTION PANEL: Key Developments Globally

7th Annual Next Generation Nicotine Delivery USA Conference

Harm Reduction PANEL: Key Developments Globally

MODERATOR: Willie McKinney Ph.D., DABT

PANELISTS: Dr. Jessica Zdinak, Sarah Marking, Marina Murphy, Tobias Baude, Joseph Smith

🎥 SCROLL DOWN TO WATCH REPLAY

This panel discussion focused on global harm reduction strategies related to nicotine and tobacco products, highlighting key markets, regulatory challenges, and cultural considerations. The discussion emphasized the complexity of implementing effective harm reduction strategies and the need for a balanced approach that incorporates regulatory, cultural, and public health perspectives.

KEY TAKEAWAYS:

• DIVERSE KEY MARKETS: Different regions, such as Asia and Sweden, showcase varying success in harm reduction based on local regulatory frameworks and consumer acceptance.

• REGULATORY CHALLENGES: The U.S. faces significant hurdles with its PMTA process, delaying product availability. In contrast, some European countries adopt a more flexible approach, allowing products to enter the market while gathering data.

• CULTURAL RELEVANCE: The success of harm reduction products hinges on aligning with local cultural norms and preferences, as demonstrated by Sweden's acceptance of oral nicotine pouches.

• YOUTH ACCESS & ILLICIT MARKETS: Concerns about youth use and the rise of illicit markets are prevalent across regions, often overshadowing evidence-based discussions on harm reduction.

• PUBLIC HEALTH FOCUS: Regulatory bodies must prioritize public health and consumer needs, providing safe alternatives to combustible cigarettes.

• COMBATTING MISINFORMATION: Addressing misinformation about nicotine and vaping is crucial for improving public perception and regulatory attitudes.

• LEARNING FROM INTERNATIONAL EXAMPLES: The panel highlighted the importance of learning from global experiences, such as the UK's successful vaping strategies and the challenges faced in Australia.

• LOOKING AHEAD: There is hope for a more evidence-based regulatory approach that considers successful international models, despite the political challenges that remain.